Prostate Cancer - Results from #760

TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations. June 19, 2024

Estimating the Effect of Radical Prostatectomy: Combining Data From the SPCG4 and PIVOT Randomized Trials With Contemporary Cohorts. June 19, 2024

Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial. June 19, 2024

Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics. June 18, 2024

Insulin resistance during androgen deprivation therapy in men with prostate cancer. June 18, 2024

Development of a Longitudinal Prostate Cancer Transcriptomic and Clinical Data Linkage. June 18, 2024

Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology. June 18, 2024

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update. June 18, 2024

Patient Perceptions of Standardized Risk Language Used in American College of Radiology Prostate MRI PIRADS Scores. June 18, 2024

Genomics in active surveillance and post-prostatectomy patients: A review of when and how to use effectively. June 17, 2024

Weekly ultra-hypofractionated radiotherapy in localised prostate cancer. June 17, 2024

Healthy lifestyle and prostate cancer risk in the Million Veteran Program. June 14, 2024

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial. June 14, 2024

External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification. June 14, 2024

Improving Distress Screening for People with Prostate Cancer: Evaluation of an E-Learning Course to Increase Healthcare Professionals' Knowledge. June 14, 2024

Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy. June 14, 2024

Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression. June 14, 2024

'It Just Makes Sense to Me': A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer. June 14, 2024

Multinational, Multicenter Evaluation of Prostate Cancer Tissue in Sub-Saharan Africa: Challenges and Opportunities. June 14, 2024

Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies. June 14, 2024

Page 39 of 1437